The total return over the past 12 months is +35.41% vs. +19.98% for the S&P 500. So far it's up +24.69% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +31.30% | +13.74% | +2.03% | +0.30% | +6.92% | +5.37% |
| Total Return CAGR | +35.41% | +18.12% | +5.46% | +3.44% | +9.69% | +7.66% |
| Revenue CAGR | +7.36% | +6.96% | +8.32% | +9.55% | +9.91% | +12.56% |
| Net Income CAGR | +8.28% | (18.47%) | (7.39%) | +0.19% | +2.55% | +6.93% |
| EPS CAGR | +6.42% | (24.78%) | (23.89%) | (11.33%) | (3.82%) | (0.31%) |
| Free Cash Flow CAGR | +145.98% | +1.45% | (10.28%) | +5.40% | +6.95% | +20.37% |
| Operating Cash Flow CAGR | +95.30% | +1.70% | +0.83% | +4.54% | +6.03% | +11.14% |
| Dividends CAGR | 0.00% | +6.53% | +5.87% | +6.63% | +14.48% | +15.64% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
CVS Health Corp. (CVS)
| Year | Start price | End price | CVS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $79.36 | $96.74 | +24.69% | +13.55% | +11.14% |
| 2025 | $44.89 | $79.36 | +84.26% | +17.72% | +66.54% |
| 2024 | $78.96 | $44.89 | (40.76%) | +24.89% | (65.65%) |
| 2023 | $93.19 | $78.96 | (12.54%) | +26.19% | (38.73%) |
| 2022 | $103.16 | $93.19 | (7.61%) | (18.17%) | +10.56% |
| 2021 | $68.30 | $103.16 | +54.87% | +28.74% | +26.13% |
| 2020 | $74.29 | $68.30 | (5.15%) | +18.37% | (23.52%) |
| 2019 | $65.52 | $74.29 | +17.26% | +31.22% | (13.96%) |
| 2018 | $72.50 | $65.52 | (7.03%) | (4.56%) | (2.47%) |
| 2017 | $78.91 | $72.50 | (5.75%) | +21.70% | (27.45%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
